Concepedia

B Credo

BC

Statistics

Publications

2

Citations

93

H-Index

2

Active since

2001

Affiliations

Abbott Fund(Current)

B Credo is an author at Abbott Fund specializing in medicine, antineoplastic drug classes, and cancer pharmacology.

Publications per year

2001–2001

2

Publications

2

A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.

Sajid Khan Tahir, Edward K. Han, B Credo et al. · PubMed · 2001 · 66 citations

, , +16

Identification and characterization of A-105972, an antineoplastic agent.

Jinshyun R. Wu‐Wong, J. D. Alder, L Alder et al. · PubMed · 2001 · 27 citations

, , +17

1–2 of 2